Status:
UNKNOWN
Expression of Th9 Cells and Poor/Non-responsiveness to Hepatitis B Vaccination
Lead Sponsor:
Beijing Municipal Science & Technology Commission
Conditions:
Hepatitis B
Eligibility:
All Genders
3-60 years
Brief Summary
An observational study will be performed in subjects aged 3-65 years old to describe the dynamic changes of cellular immunity after vaccination of hepatitis B vaccine, and to find out the expression l...
Detailed Description
This study selected 74 volunteers which had the hepatitis B vaccine (immunization programs 0,1,6) , anti-HBs≤10mIU as the research subjects, and choose 20 volunteers which anti-HBs≥1000mIU as the cont...
Eligibility Criteria
Inclusion
- volunteer
- between 3-60 years old
- healthy
- have the history of vaccination of hepatitis B.
- Recent serological testing result show HBsAg, HBeAg, anti-HBe, anti-HBc, HBV DNA and Pre-S1 should be negative.
- informed consent
- not allergic to the component of the vaccine
Exclusion
Key Trial Info
Start Date :
August 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2012
Estimated Enrollment :
94 Patients enrolled
Trial Details
Trial ID
NCT01441609
Start Date
August 1 2011
End Date
May 1 2012
Last Update
September 28 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chifeng, Inner Mongolia, China, 024000